Urinary Schistosomiasis: Review

In this review, the clinical manifestations of urinary schistosomiasis are displayed from a pathogenetic perspective. According to the prevailing host’s immune response profile, urinary schistosomiasis may be broadly categorized into cell-mediated and immune-complex-mediated disorders. The former, u...

Full description

Bibliographic Details
Main Author: Rashad S. Barsoum
Format: Article
Language:English
Published: Elsevier 2013-09-01
Series:Journal of Advanced Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2090123212000628
_version_ 1819043112608071680
author Rashad S. Barsoum
author_facet Rashad S. Barsoum
author_sort Rashad S. Barsoum
collection DOAJ
description In this review, the clinical manifestations of urinary schistosomiasis are displayed from a pathogenetic perspective. According to the prevailing host’s immune response profile, urinary schistosomiasis may be broadly categorized into cell-mediated and immune-complex-mediated disorders. The former, usually due to Schistosoma haematobium infection, are attributed to the formation of granulomata along the entire urinary tract. As they heal with excessive fibrosis, they may lead to strictures, calcifications and urodynamic abnormalities. The main impact is lower urinary, the site of heaviest ovi-position. Secondary bacterial or viral infection is common, any may be incriminated in secondary stone formation of the development of bladder malignancy. Immune-complex mediated lesions are usually associated with hepatosplenic schistosomiasis due to Schistosoma mansoni infection. Circulating complexes composed of schistosomal gut antigens and different classes of immunoglobulins deposit in the kidneys leading to several patterns of glomerular pathology. The latter have been categorized under six classes based on the histological and immunofluorescence profile. These classes have been linked to respective clinical manifestations and depend on the stage of evolution of the host’s immune response, extent of associated hepatic fibrosis and co-infection with salmonella or hepatitis C. Secondary amyloidosis develops in 15% of such patients, representing a critical impairment of macrophage function. Conclusion: The wide clinicopathological spectrum of urinary schistosomiasis mirrors the evolution of the host’s immune response according to chronicity of infection, bacterial or viral co-infection and, in the case of glomerulonephritis, to the extent of hepatic co-morbidity.
first_indexed 2024-12-21T09:51:36Z
format Article
id doaj.art-aae3c0fff5c441379175c83832f7caab
institution Directory Open Access Journal
issn 2090-1232
2090-1224
language English
last_indexed 2024-12-21T09:51:36Z
publishDate 2013-09-01
publisher Elsevier
record_format Article
series Journal of Advanced Research
spelling doaj.art-aae3c0fff5c441379175c83832f7caab2022-12-21T19:08:10ZengElsevierJournal of Advanced Research2090-12322090-12242013-09-014545345910.1016/j.jare.2012.08.004Urinary Schistosomiasis: ReviewRashad S. BarsoumIn this review, the clinical manifestations of urinary schistosomiasis are displayed from a pathogenetic perspective. According to the prevailing host’s immune response profile, urinary schistosomiasis may be broadly categorized into cell-mediated and immune-complex-mediated disorders. The former, usually due to Schistosoma haematobium infection, are attributed to the formation of granulomata along the entire urinary tract. As they heal with excessive fibrosis, they may lead to strictures, calcifications and urodynamic abnormalities. The main impact is lower urinary, the site of heaviest ovi-position. Secondary bacterial or viral infection is common, any may be incriminated in secondary stone formation of the development of bladder malignancy. Immune-complex mediated lesions are usually associated with hepatosplenic schistosomiasis due to Schistosoma mansoni infection. Circulating complexes composed of schistosomal gut antigens and different classes of immunoglobulins deposit in the kidneys leading to several patterns of glomerular pathology. The latter have been categorized under six classes based on the histological and immunofluorescence profile. These classes have been linked to respective clinical manifestations and depend on the stage of evolution of the host’s immune response, extent of associated hepatic fibrosis and co-infection with salmonella or hepatitis C. Secondary amyloidosis develops in 15% of such patients, representing a critical impairment of macrophage function. Conclusion: The wide clinicopathological spectrum of urinary schistosomiasis mirrors the evolution of the host’s immune response according to chronicity of infection, bacterial or viral co-infection and, in the case of glomerulonephritis, to the extent of hepatic co-morbidity.http://www.sciencedirect.com/science/article/pii/S2090123212000628GlomerulonephritisHepatosplenic schistosomiasisAmyloidosisBladder cancerSalmonellosisHepatitis C
spellingShingle Rashad S. Barsoum
Urinary Schistosomiasis: Review
Journal of Advanced Research
Glomerulonephritis
Hepatosplenic schistosomiasis
Amyloidosis
Bladder cancer
Salmonellosis
Hepatitis C
title Urinary Schistosomiasis: Review
title_full Urinary Schistosomiasis: Review
title_fullStr Urinary Schistosomiasis: Review
title_full_unstemmed Urinary Schistosomiasis: Review
title_short Urinary Schistosomiasis: Review
title_sort urinary schistosomiasis review
topic Glomerulonephritis
Hepatosplenic schistosomiasis
Amyloidosis
Bladder cancer
Salmonellosis
Hepatitis C
url http://www.sciencedirect.com/science/article/pii/S2090123212000628
work_keys_str_mv AT rashadsbarsoum urinaryschistosomiasisreview